Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells

Cell Transplantation

Volumn 9, Issue 4, 2000, Pages 471-484

  Zurn, A D ^a   Henry, H ^a   Schluep, M ^a   Aubert, V ^a   Winkel, L ^a   Eilers, B ^a   Bachmann, C ^a   Aebischer, P ^a  

^a University of Lausanne Medical Center   (Switzerland)

Author keywords

Amyotrophic lateral sclerosis; Encapsulated cells; Immune response; Xenotransplantation

Indexed keywords

ANTIBODY; ANTIGEN; CILIARY NEUROTROPHIC FACTOR; FETUIN; POLYMER;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; ASTHENIA; CATTLE; CELL STRAIN BHK; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG IMPLANT; DRUG SAFETY; DRUG TOLERABILITY; ENCAPSULATION; FEMALE; GENETIC ENGINEERING; HUMAN; HUMORAL IMMUNITY; LEUKOCYTE COUNT; MALE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; XENOGRAFT;

EID: 0033771207     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970000900404     Document Type: Article

References (40)

1. Long-term cross-species brain transplantation of a polymer encapsulated dopamine-secreting cell line
2. Gene therapy for amyotrophic lateral sclerosis using a polymer encapsulated xenogeneic cell line engineered to secrete hCNTF
3. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients
4. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human CNTF in amyotrophic lateral sclerosis
5. Basic local alignment search tool
6. Quantitative motor assessment in amyotrophic lateral sclerosis
7. Immunologically privileged sites
8. A non-linear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale
9. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic, or xenogeneic embryonic neuronal tissue in rats
10. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: A major obstacle for xenotransplantation in humans
11. CNS antigen presentation
12. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle
13. Microheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: Apparent deficiencies in clusterin and serum amyloid P
14. Methods for increasing the resolution of two-dimensional protein electrophoresis
15. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: An annotated update
16. Maturation of the head of bacteriophage T4. IV. The proteins of the core of the tubular polyheads and in vitro cleavage of the head proteins
17. A semidry electroblotting system efficiently transfers both high- and low-molecular-weight proteins separated by SDS-PAGE
18. Modified dot assay with increased sensitivity: Detection of small amounts of immunoglobulin molecules and the importance of different detection systems
19. The fate of allogeneic and xenogeneic tissue transplanted to the third ventricle of rodents
20. The impact of cyclosporin A on transplantation
21. The administration of guanidine in amyotrophic lateral sclerosis
22. Evaluation of intracerebral grafting of dopamine-secreting PC 12 cells into allogeneic and xenogeneic brain
23. MHC antigen presentation in spontaneous and induced rejection of neural xenografts
24. Motor neuron disease and animal models
25. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response with the central nervous system
26. The intrathecal, poly-specific and oligoclonal immune response in multiple sclerosis
27. Polymer encapsulated cell lines genetically engineered to release CNTF can slow down progressive motor neuronopathy in the mouse
28. Anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis
29. Ciliary neurotrophic factor prevents the degeneration of motoneurons after axotomy
30. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management
31. Microdroplet testing for HLA A, -B, -C, and -D antigens
32. Clinical value of specific intrathecal production of antibodies
33. GDNF reduces drug-induced rotational behavior following medial forebrain bundle transection by a mechanism not involving striatal dopamine
34. Prolongation of pig islet xenograft survival in rats immunosuppressed with FK- 506
35. Intrathecal application of interferon gamma: Progressive appearance of MHC antigens within the rat nervous system
36. Cellular immune reactivity within the CNS
37. Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways
38. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death
39. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons
40. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurons